Novavax (NVAX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.11 +1.10%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Nucor projects Q3 2026 earnings above prior year, below estimates
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
